Feb 24 (Reuters) - Regis Healthcare Ltd REG.AX
* Anticipates H2 ebitda to be in line with H1 result
* Total capex spend in FY17 is anticipated to be in order of $160 MLN
* FY17 net rad inflows are anticipated to be circa $100 MLN following first half result of $46.6 MLN
* FY17 depreciation expense range is anticipated to be $28 MLN - $31 MLN, following a H1 expense of $14.2MLN
* Interest expense for FY17 is anticipated to be circa $8 MLN for full year
* Debt will remain at approximately 2X ebitda in FY2017 Source text for Eikon: ID:nASX9JVTkL Further company coverage: REG.AX